Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma Meeting Abstract
| Authors: | Ku, G. Y.; Wu, A. J. C.; Sihag, S.; Park, B. J.; Jones, D. R.; Gu, P.; Maron, S. B.; Sugarman, R.; Chalasani, S. B.; Shcherba, M.; Feder, L.; Cowie, K.; Norris, J.; Johnson, V.; Tang, L. H.; Ilson, D. H.; Janjigian, Y. Y.; Molena, D. |
| Abstract Title: | Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800258 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.226 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 226 -- Source: Wos |
